Biopsy

A prostate biopsy, also known as a core needle biopsy or a transrectal ultrasound (TRUS), is used to determine if any suspicious looking tissues are cancerous or not. A biopsy is conducted when an abnormal lump is found during a digital rectal exam (DRE) or if the prostate-specific antigen (PSA) blood test reveals high levels of PSA.

Prostate Cancer Canada graciously acknowledges the Princess Margaret Cancer Centre for sharing this video with us.
 
How is a biopsy performed?
  • You will be given a local anesthetic. 
  • A biopsy needle and ultrasound probe is then inserted into your rectum. Your doctor will use the ultrasound as a visual aid to help him/her guide the needle through your rectum. The needle quickly pierces through the rectal wall, enters the prostate and removes a tissue sample.
  • 8-12 samples will be taken depending on the area to be examined.
  • Procedure lasts between 15 and 20 minutes. 
What can I expect after the procedure?
 
Everyone responds differently to procedures. Following a prostate biopsy, it is common to experience the following:
  • Bleeding from your rectum or penis
  • Blood in the stool, urine or semen
  • Pain
These common symptoms may persist for 2 weeks or more. If you have concerns about these symptoms, discuss them with your doctor.


 

For more information and support:


Plaid for Dad


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More

Landmark study links tumour evolution to prostate cancer severity

Toronto (April 19, 2018) – Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumour has evolved.
More


Click here for news archive